This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...

Recalls of more ranitidine products are expected to continue this week after preliminary tests found low levels of nitrosamines in the medicines. A spokesperson from...

The popularisation of meprobamate from the 1950s onwards ushered in the dawn of the psychopharmacological era where patients began to look to doctors to...

Pharmacists play a referring role in supporting patients with dry eye. Dry eye is a common problem, increasing in older age. Most cases are mild,...

Cardiovascular disease is the largest cause of death in Australian women and pharmacists can help them check their heart health and manage their risk...

The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...

This week marks the beginning of spring and National Asthma Week, a time when the National Asthma Council (NAC) urges Australians with asthma to...

Pharmacists can minimise opioid harm by helping patients step down. While opioids play an important role in the management of acute pain, their widespread use...

The Therapeutic Goods Administration (TGA) has made a final decision on the rescheduling of modified release (MR) paracetamol due to safety concerns.  The safety of...

Symbicort prn is now indicated to treat mild asthma flare-ups after an extended indication was approved by the TGA. Symbicort Turbuhaler and Rapihaler are now...